With the MAHA movement poised to introduce a lot more "integrative" or "complementary and alternative" treatments into oncology (and medicine in general), a new study shows the likely result.
2hon MSN
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...
AstraZeneca's cancer immunotherapy Imfinzi has been approved in the EU for use before and after surgery for early-stage ...
Joe Till, 33, first went to walk-in centres complaining of pain in his leg but was reassured it was nothing serious. Months ...
Colorectal cancer, or cancer of the bowel or rectum, has long been associated with older adults. However, in recent years, cases among people under 50 have surged.
The former Syracuse player, who is the son of an ex-NFL star, only popped the question to fiancee Savanna Morgan last month.
AstraZeneca said it received European Union approval for its Imfinzi drug as a treatment for early-stage gastric and gastroesophageal cancers, expanding the label of one of its top-selling oncology ...
A living will ensures your treatment preferences are honored, preventing unnecessary suffering and easing family ...
As an employee of Henry Ford Health for more than 20 years, Brooke Wessman focused on health care process improvement in ...
A teacher said she is "facing a death sentence" after battling a form of cancer known as the silent killer. Emma Durkin was diagnosed with stage three ovarian cancer after initially believing she was ...
In 2025, CytomX remained focused on controlling costs and efficiently progressing its pipeline programs. Total operating expense for 2025 was $98.6 million compared to $113.1 million for 2024, a ...
Starting in October 2025, the expansion doses of 8.6 mg/kg and 10 mg/kg were prioritized for dose optimization utilizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results